Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Micro Cap & Branchenriese: Heute rein? - Partnerschaft entfacht Übernahmefantasien!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 3084 | ISIN: DE00000TUEV1 | Ticker-Symbol: -
1-Jahres-Chart  (nicht börsennotiert)
TUV RHEINLAND AG Chart 1 Jahr
PR Newswire
485 Leser
Artikel bewerten:
(2)

ProLogium Sets Record-Breaking Standards in Battery Safety and Energy Density Ahead of Schedule with TÜV Rheinland Certification

Finanznachrichten News

TAOYUAN, Dec. 13, 2024 /PRNewswire/ -- ProLogium Technology, a global leader in next-generation lithium ceramic batteries, reached a significant milestone on December 6, 2024, by earning latest TÜV Rheinland certification-an internationally respected benchmark for battery safety and performance. Following its initial certification in March 2024, ProLogium has made this record-breaking breakthrough in less than a year. The TÜV Rheinland certification confirms that ProLogium's next-generation lithium ceramic battery delivers an industry-leading energy density of 811.6 Wh/L (volumetric) and 359.2 Wh/kg (gravimetric).

This milestone not only fulfills ProLogium's market commitment a year ahead of schedule but also stands out as a product of its gigafactory's pilot production line. In a highly competitive industry where annual advancements are rare, ProLogium has achieved successive breakthroughs within nine months, continuously surpassing industry benchmarks. These accomplishments highlight ProLogium's unparalleled innovation and development capabilities, paving the way for the healthy growth of the global electric vehicle (EV) industry.

A Groundbreaking Achievement: ProLogium's Founder Reflects
ProLogium's Founder and Chairman, Vincent Yang, emphasized the significance of this achievement:
"This milestone embodies our unwavering spirit of innovation and demonstrates our commitment to market promises. It reflects 18 years of relentless efforts in addressing key battery challenges and optimizing manufacturing processes. From redefining safety standards with our globally leading separator-free ceramic layer technology to enhancing performance with the first 100% composite silicon anode, and securing hundreds of interfacial resistance patents, ProLogium has consistently turned technical challenges into driving forces for innovation. These achievements lay a solid foundation for accelerating technological advancements."
Yang also announced plans to unveil further groundbreaking innovations at CES 2025, reaffirming ProLogium's position as a technology leader.

Steady Technological Progress
In March 2024, ProLogium achieved TÜV Rheinland certification for its battery's energy density at 749 Wh/L (volumetric) and 321 Wh/kg (gravimetric). By December, ProLogium has raised the bar to 811.6 Wh/L and 359.2 Wh/kg, exceeding its October forecast. These results represent a remarkable 8.36% and 11.90% improvement, respectively, showcasing its profound technical expertise.

ProLogium's batteries outperform mainstream alternatives, offering up to 79.6% higher energy density than LFP (below 200 Wh/kg) and NMC batteries (200-300 Wh/kg). This translates to smaller, lighter battery packs with longer range and improved energy efficiency. Additionally, ProLogium's 5-minute charging technology-enabling a 300 km drive-redefines the industry's fast-charging standards, significantly reducing charging time by 83.3% compared to the conventional 30 minutes, offering a refueling experience comparable to gasoline vehicles.

Full report is available at Prologium's website: https://prologium.com/prologium-sn09-tuv-pressrelease/

A Safer, More Efficient Future
As the EV industry embraces a new era of safety and performance, ProLogium remains committed to advancing cutting-edge technologies and leveraging its manufacturing excellence to deliver safer, higher-performing driving experiences. Harnessing its robust innovation capabilities, ProLogium is nurturing a thriving ecosystem for the EV industry by providing scalable, high-performance battery solutions and advancing global efforts toward a net-zero and sustainable future.

About ProLogium
Founded in 2006, ProLogium Technology is an energy innovation company specializing in the development and manufacturing of next-generation lithium ceramic batteries. ProLogium provides advanced lithium ceramic battery solutions for electric vehicles, consumer markets, and industrial applications. Its proprietary technologies are protected by over 900 global patents (granted and pending). The company has delivered more than 12,000 lithium ceramic battery samples to global automakers for testing and module development.
ProLogium's first gigawatt-hour-scale giga-factory production demonstration line, located in Taoyuan, Taiwan, commenced production in 2024 to serve the global market.
In May 2024, ProLogium announced its first overseas R&D center in Paris-Saclay, dedicated to tailoring solutions for the European market. Meanwhile, ProLogium's first overseas giga-factory project in Dunkirk, France, has completed the first and second phases of public hearings and is currently in the environmental assessment and construction permit evaluation stages. The project is expected to receive its building permit by late 2024, begin construction in early 2025, and start mass production by 2027.

Cision View original content:https://www.prnewswire.co.uk/news-releases/prologium-sets-record-breaking-standards-in-battery-safety-and-energy-density-ahead-of-schedule-with-tuv-rheinland-certification-302330973.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.